50726-52-8

RUTHENIUM(3+),PENTAAMINE(DL-HISTIDINE-N3)-,TRICHLORIDE,(OC-6-22)-

2H-1,4-Benzodiazepin-2-one,1-(5-aminopentyl)-7-chloro-1,3-dihydro-5-(4-hydroxyphenyl)-3-(2-naphthalenylmethyl)-, (3S)-

3-Pyrrolidinecarboxamide,N-methyl-2-oxo-1-[4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]-

2H-1,3-Thiazin-5-ol,5,6-dihydro-2-imino-4-(4-methylphenyl)-6-(4-nitrophenyl)-

2-Naphthalenecarboxylic acid, 5,6,7,8-tetrahydro-5,5-dimethyl-, methylester

2-Furancarbonitrile, tetrahydro-3,3-dimethyl-2,5-diphenyl-, (2R,5S)-rel-

2-Naphthalenecarboxylic acid, 3,5,6,7,8,8a-hexahydro-1,5,5-trimethyl-,ethyl ester

2-Furancarbothioamide, N-(4-iodophenyl)-

2-Furancarboxaldehyde, 4-(4-amino-2-hydroxyphenyl)-

2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,5-dihydro-

2-Furancarboxaldehyde, 5-[4-(trifluoromethyl)phenyl]-

2H-1,4-Benzodiazepin-2-one, 7-ethynyl-5-(2-fluorophenyl)-1,3-dihydro-

2-Furancarboxaldehyde, 5-nitro-, dimethylhydrazone

2-Naphthalenecarboxylic acid, 3-hydroxy-7-(4-methoxyphenyl)-

2-Furanbutanenitrile,3-(dimethoxymethyl)tetrahydro-a-(triphenylphosphoranylidene)-

2H-1,4-Benzodiazepin-2-one,5-(2-chlorophenyl)-1,3-dihydro-7-[(trimethylsilyl)ethynyl]-

2-Furancarboxamide, 5-(4-morpholinylmethyl)-N-2-pyridinyl-,monohydrochloride

2H-1,3-Oxazine-2,4(3H)-dione,6-methyl-3-(3,4,5,6-tetrachloro-2-pyridinyl)-

2-Furancarboxamide, 3-methyl-N-[2-(4-methylphenyl)ethyl]-

1,2,4-Triazine, 6-(4-butoxyphenyl)-3-[4-(pentyloxy)phenyl]-

2-Propenamide,N-[2-[(aminocarbonyl)hydroxyamino]-1-methylethyl]-3-(4-bromophenyl)-,(R)-

2-Furancarboxamide, 5-(chloromethyl)-N-2-pyridinyl-

2-Propenamide, N-[2-[(aminocarbonyl)hydroxyamino]ethyl]-3-phenyl-

2-Naphthalenecarboxylic acid, 3-[(6,7-dimethoxy-4-quinolinyl)oxy]-,propyl ester

2-Naphthalenecarboxylic acid, 6-(1-hydroxy-2-propenyl)-

1,2,4-Triazine, 6-(4-butylphenyl)-3-[4-(decyloxy)phenyl]-

Pyridine, 2-(chlorophenylmethyl)-

2-Furancarboxamide, N-(2-chlorophenyl)-5-(2-nitrophenyl)-

2H-1,3-Oxazine-2,4(3H)-dione,3-[4,6-bis(trichloromethyl)-1,3,5-triazin-2-yl]-6-methyl-

2H-1,3-Thiazete, 4-(4-methylphenyl)-2,2-bis(trifluoromethyl)-

2-Furancarboxamide, 5-[2-(2-furanyl)-6-(2-thienyl)-4-pyridinyl]-

1H-Indene, 3-bromo-1-(bromophenylmethylene)-2-phenyl-, (1E)-

2-Furancarboxamide, 5-[2-(2-furanyl)-6-phenyl-4-pyridinyl]-

2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-phenyl-,[2-chloro-1-(chloromethyl)ethylidene]hydrazone

2-Naphthalenecarboxylic acid, 3-cyanato-, ethyl ester

2H-1,3-Oxazine-2,6(3H)-dione, 4-methyl-5-phenyl-

2H-1,4-Benzodiazepin-2-one,1,3,4,5-tetrahydro-3-(1-methylethyl)-1-(2-phenylethyl)-7-propoxy-, (3S)-

50726-52-8 msds

CAS No 50726-52-8 supplier

CASNo 50726-52-8 distributor

CAS # 50726-52-8 manufacturer

CAS Number 50726-52-8 safety

CAS RN 50726-52-8 wholesale

2026-10-12 Find RUTHENIUM(3+),PENTAAMINE(DL-HISTIDINE-N3)-,TRICHLORIDE,(OC-6-22)-,CAS No.50726-52-8,Formula:C6H24Cl3N8O2Ru in 9CMX